The Claim
Colibactin-induced mutational signatures SBS88 and ID18 are significantly more prevalent in colorectal cancers diagnosed before age 40 than in those diagnosed after age 70, with a 3.3-fold higher frequency in early-onset cases, indicating a potential association between early-life exposure to colibactin-producing bacteria and accelerated tumorigenesis in the distal colon and rectum.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Colorectal cancers diagnosed before age 40 are more likely to show specific DNA damage patterns linked to colibactin-producing bacteria than cancers diagnosed after age 70, suggesting that exposure to these bacteria earlier in life may be associated with faster development of tumors in the lower colon and rectum.
See the scientific wording
Colibactin-induced mutational signatures SBS88 and ID18 are significantly more prevalent in colorectal cancers diagnosed before age 40 compared to those diagnosed after age 70, occurring 3.3 times more frequently in early-onset cases, suggesting early-life exposure to colibactin-producing bacteria may contribute to accelerated tumorigenesis in the distal colon and rectum.
What the research says
1 studyStudy: Geographic and age variations in mutational processes in colorectal cancer
This study found that a specific type of DNA damage caused by certain gut bacteria is much more common in young people who get colon cancer than in older people, suggesting these bacteria might help cause cancer earlier in life.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.